•An executive with a long and varied history in the biotechnology
sector, Dr. Lindsay Rosenwald has spent more than 25 years
investing in and leading innovative companies toward success.
•Today, Dr. Lindsay Rosenwald builds on his record as a founding
partner of Opus Point Partners, a health care and life sciences asset
management firm based in New York City.
•Launched in 2009, Opus Point Partners was founded to identify and
claim significant investment opportunities in biotech companies with
the potential for major, long-term returns.
•Alongside its Opus Point Healthcare Innovations Fund, the company
focuses on publicly traded entities with a demonstrated track record
and clear plans for future success.
•Since it began, Opus Point Partners has attracted an experienced
team of executives, analysts, and research associates dedicated to
selecting highly promising investment opportunities.
A particular slide catching your eye?
Clipping is a handy way to collect important slides you want to go back to later.